INnovative Steroid Treatment to reduce Asthma development in children after first-time Rhinovirus-induced wheezing (INSTAR): protocol for a randomised placebo-controlled trial

INnovative Steroid Treatment to reduce Asthma development in children after first-time Rhinovirus-induced wheezing (INSTAR): protocol for a randomised placebo-controlled trial

Introduction Asthma is a leading cause of morbidity and healthcare use among children. Risk factors of childhood asthma include atopic predisposition and severe wheezing episodes caused by rhinovirus infection in early life. In children with first-time rhinovirus-induced wheezing, we aim to study th...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Vollsæter, Knut Øymar, Svein Arne Nordbø, Tytti Vuorinen, Kari Risnes, Claus Klingenberg, Tuomas Jartti, Henrik Døllner, Anna Partty, Håvard Ove Skjerven, Turid Follestad, Trude Elvebakk, Heidi Jartti, Silje Nerheim, Nina Moe, Johanna Koski, Anita Hofstad, Carina Bjørkvoll Leknessund, Cilla Söderhäll, Erle Sissener, Christopher Stephen Inchley, Jon R Konradsen
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/7/e103530.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/15/7/e103530.full

Similar Items